Related Experiment Video

Updated: May 23, 2026

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
07:48

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia

Published on: June 8, 2019

A Renewed Emphasis on Therapeutic Angiogenesis Research for CAD

Jack Jacobs1

  • 1Jack Jacobs, PhD, is chief scientific officer and chief operating officer at CardioVascular BioTherapeutics, in Las Vegas.

Biotechnology Healthcare
|April 6, 2012
PubMed

Insights

New research into angiogenesis may offer hope for "no-option" patients with clogged arteries due to coronary artery disease or heart failure. This approach could potentially unblock arteries where traditional methods have failed.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Biotechnology

Background:

  • Coronary artery disease and congestive heart failure significantly impact patient quality of life.
  • "No-option" patients with these conditions have limited treatment pathways for severe arterial blockages.
  • Current treatments for severe arterial blockages in these patients are often ineffective or unavailable.

Purpose of the Study:

  • To explore the potential of angiogenesis research in treating "no-option" patients.
  • To identify novel therapeutic strategies for unblocking arteries in patients with advanced cardiovascular disease.
  • To overcome previous setbacks in angiogenesis research for cardiovascular applications.

Main Methods:

  • Review of current angiogenesis research and its application to cardiovascular disease.
  • Analysis of potential molecular targets and pathways involved in therapeutic angiogenesis.
  • Evaluation of preclinical and clinical data from angiogenesis-related studies.

Main Results:

  • Angiogenesis research presents a promising avenue for treating "no-option" cardiovascular patients.
  • Despite past challenges, advancements in understanding angiogenic mechanisms offer new possibilities.
  • Targeted therapeutic angiogenesis could potentially restore blood flow in previously untreatable arterial blockages.

Conclusions:

  • Therapeutic angiogenesis holds significant potential for "no-option" patients with coronary artery disease and congestive heart failure.
  • Further research and development are crucial to overcome previous setbacks and translate findings into clinical practice.
  • Angiogenesis may provide a viable solution for previously untreatable arterial blockages, improving patient outcomes.

More Related Videos

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits07:34

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...